Literature DB >> 6183539

Deficient natural killer cell activity in patients with idiopathic dilated cardiomyopathy.

J L Anderson, J F Carlquist, E H Hammond.   

Abstract

Dilated (congestive) cardiomyopathy is a disease of uncertain aetiology in which viral and immune factors are postulated to be of importance. Natural killer cells mediate natural resistance to viral infections and certain tumours. To evaluate natural killer (NK) activity in patients with cardiomyopathy, circulating peripheral blood mononuclear cells were obtained from 16 patients, from 54 normal blood donors, and from 14 patients with heart failure due to other causes (primarily coronary disease). NK activity was assessed as a lymphocyte to target cell ratio causing 50% killing (L/T50). L/T50 in normals was 17.2 +/- 11.4. A normal L/T50 distribution was also noted in heart failure controls (L/T50 = 19.6 +/- 9.9) and 8/16 cardiomyopathy patients (L/T50 = 17.5 +/- 9.5). NK activity was deficient (L/T50 greater than or equal to 50) in 8/16 patients with cardiomyopathy but in only 2/54 normals (p less than 0.001) and 0/14 heart failure controls (p less than 0.01). Of the several clinical and laboratory variables examined, only the frequency of the HLA-A3 tissue type was associated with NK deficiency. NK deficiency is an independent disease marker in about 50% of patients with cardiomyopathy and should be evaluated for a possible role in its pathogenesis.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6183539     DOI: 10.1016/s0140-6736(82)92786-6

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  16 in total

1.  Phenotype of early cardiomyopathic changes induced by active immunization of rats with a synthetic peptide corresponding to the second extracellular loop of the human beta-adrenergic receptor.

Authors:  L Buvall; E Bollano; J Chen; W Shultze; M Fu
Journal:  Clin Exp Immunol       Date:  2006-02       Impact factor: 4.330

2.  Myofibrillar protein structure and assembly during idiopathic dilated cardiomyopathy.

Authors:  R J Levine; J B Caulfield; P Norton; P D Chantler; M R Deziel; H S Slayter; S S Margossian
Journal:  Mol Cell Biochem       Date:  1999-05       Impact factor: 3.396

Review 3.  Natural killer cells in inflammatory heart disease.

Authors:  SuFey Ong; Noel R Rose; Daniela Čiháková
Journal:  Clin Immunol       Date:  2016-11-25       Impact factor: 3.969

4.  Absence of linkage between idiopathic dilated cardiomyopathy and candidate genes involved in the immune function in a large Italian pedigree.

Authors:  M Krajinovic; L Mestroni; G M Severini; B Pinamonti; F Camerini; A Falaschi; M Giacca
Journal:  J Med Genet       Date:  1994-10       Impact factor: 6.318

5.  Do specific HLA antigens predispose to ischaemic heart disease or idiopathic dilated cardiomyopathy?

Authors:  S C Grant; S Sheldon; P A Dyer; R D Levy; N H Brooks
Journal:  Br Heart J       Date:  1994-01

6.  Interleukin-2 enhances the cytotoxic activity of circulating natural killer cells in patients with chronic heart failure.

Authors:  Heng-Chen Yao; Shu-Qin Liu; Ke Yu; Min Zhou; Le-Xin Wang
Journal:  Heart Vessels       Date:  2009-07-22       Impact factor: 2.037

7.  Extracellular matrix remodelling after coxsackievirus B3-induced murine myocarditis.

Authors:  R M Gómez; C G Castagnino; M I Berría
Journal:  Int J Exp Pathol       Date:  1992-10       Impact factor: 1.925

8.  Increased circulating cytokines in patients with myocarditis and cardiomyopathy.

Authors:  A Matsumori; T Yamada; H Suzuki; Y Matoba; S Sasayama
Journal:  Br Heart J       Date:  1994-12

9.  Clinical aspects of myocarditis.

Authors:  P J Richardson
Journal:  Heart Vessels Suppl       Date:  1985

10.  Profiles of biopsy-proven cases with myocarditis.

Authors:  W Ruzyłło; A Rosnowski; M Dabrowski
Journal:  Heart Vessels Suppl       Date:  1985
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.